DermaClip Names John W. Berry as Chief Commercial Officer

John Berry named DermaClip Chief Commercial Officer

Houston, TX – 07/01/2022. DermaClip® US, L.L.C., the producer and distributor of DermaClip® and DermaQuik® skin closure devices, the next generation wound closure device optimizing wound closure, today announced the election of John W. Berry as its Chief Commercial Officer. A proven sales and marketing executive with over 30 years’ experience growing sales teams and generating explosive market growth for a range of medical device and technology companies, Mr. Berry brings his expertise to the DermaClip team to advance and empower the Company’s sales and marketing efforts in both the national and international markets.

Charles Darling, CEO of DermaClip, stated: “We are excited to have John join our team. With his stellar reputation in the industry and his proven capability to build marketing teams and sales, we have added a critical component to drive adoption of the DermaClip skin closure devices as the optimized solution for wound closure for the patient, for the clinician, and for the health institution. We welcome him to our team.”

About DermaClip®

DermaClip US, L.L.C. produces wound closure devices that are designed to optimize wound closure on patients, secure good healing results, make wound closure more efficient and less painful, and save time for all involved in the process. The Company’s patented devices have been used to close all types of wounds on all ages of patients, encompassing the full range from children to geriatrics. The devices have been used under all types of conditions, from treating injured warfighters in the field with the US Military, to the Emergency Room, the Urgent Care, the Operating Room and in doctor’s offices. You can see more about the devices at and

You can also find more about the DermaClip devices on Twitter, Facebook, LinkedIn, and Instagram.